Posachedwapa, Center for Drug Evaluation (CDE) ya China's National Medical Products Administration (NMPA) yalengeza kuti Encorafenib yavomerezedwa kwakanthawi kuti iwunikidwenso. Idzagwiritsidwa ntchito limodzi ndi cetuximab ndi FOLFOX chemotherapy regimen ngati chithandizo choyamba kwa odwala akuluakulu omwe ali ndi khansa ya BRAF V600E-mutant metastatic colorectal.

Izi zikusonyeza kupita patsogolo kwakukulu kwa chithandizo cha khansa yovuta kuchiza yomwe imayambitsidwa ndi kusintha kwa majini.
**Kodi Encorafenib ndi chiyani ndipo n’chifukwa chiyani ili yofunika?**
Encorafenib ndi mankhwala oletsa khansa ang'onoang'ono a BRAF omwe amasankhidwa kwambiri, omwe amapikisana ndi ATP. Mwachidule, amalimbana mwachindunji ndi maselo otupa omwe ali ndi kusintha kwa BRAF V600E, zomwe zimalepheretsa kukula ndi kufalikira kwawo. Poyerekeza ndi mankhwala ena oletsa khansa a BRAF omwe adavomerezedwa kale, Encorafenib ili ndi mphamvu yayitali ya mankhwala, zomwe zikutanthauza kuti imakhalabe yogwira ntchito m'thupi kwa nthawi yayitali.
**Deta ya Zachipatala: Umboni wa Kugwira Ntchito Bwino**
Pa Januwale 25, 2025, *Nature Medicine* inafalitsa kafukufuku wachipatala wa Gawo 3 wa Encorafenib + Cetuximab + chemotherapy pochiza khansa ya m'matumbo yosinthika ya BRAF. Kafukufuku wa BREAKWATER (NCT04607421) cholinga chake chinali kuwunika momwe encorafenib pamodzi ndi cetuximab alili kapena alibe chemotherapy wamba mwa odwala omwe ali ndi khansa ya m'matumbo yosinthika ya BRAF V600E. Odwala onse 236 adasankhidwa mwachisawawa ku gulu loyesera ndipo 243 ku gulu lowongolera. Zotsatira zake zinawonetsa kuchuluka kwa yankho lotsimikizika (cORR) kwa 60.9% mu gulu loyesera, pomwe odwala atatu adapeza yankho lathunthu (CR), 64 partial response (PR), ndi 31 stable disease (SD). Mu gulu lowongolera, cORR inali 40.0%, ndi 2 CR, 42 PR, ndi 34 SD. Nthawi yapakati yoyankha (DOR) inali miyezi 13.9 ndi miyezi 11.1, motsatana. Kupulumuka kwapakati konse sikunali koyembekezeka mu gulu loyesera, poyerekeza ndi miyezi 14.6 mu gulu lowongolera.
**Kwa Odwala Padziko Lonse: Dipatimenti Yapadziko Lonse ya Chipatala cha Oncology ku Beijing South Region imapereka chithandizo chapamwamba**
Njira yochizira yapamwambayi tsopano yalowa m'njira yofunika kwambiri yowunikira ku China. Kwa odwala ochokera kumayiko ena—ngati inu kapena wachibale wanu mukufuna njira zabwino zochizira—Beijing South Region Oncology Hospital International Department yadzipereka kukhala ngati mlatho wopita ku ukadaulo wapamwamba wa zamankhwala padziko lonse lapansi. Timayang'anira kwambiri chitukuko cha mankhwala padziko lonse lapansi ndipo timapereka upangiri waukadaulo ndi chithandizo chamankhwala kwa odwala oyenerera.
**Lumikizanani Nafe Lero Kuti Muyambe Ulendo Wanu wa Chiyembekezo**
Musadikire. Mwayi uliwonse wopeza chithandizo uli ndi kuthekera kosintha moyo. Gulu lathu lopereka chithandizo cha zilankhulo zosiyanasiyana lili okonzeka kupereka upangiri, nthawi yokumana ndi dokotala, komanso chitsogozo cha zachipatala.
����Nambala Yofunika Kwambiri: 400-880-3716
����Lumikizanani nafe nthawi yomweyo pa WeChat: ID: 17801183037
����Imelo:
- Primary: `100085_010@163.com`
- Backup: `myimmnet@163.com`
Mungathe kutifikira kudzera mu njira iliyonse yomwe ili pamwambapa. Ogwirizanitsa odwala athu apadziko lonse lapansi adzayankha mwachangu kuti athandize pakukonzekera zolemba zachipatala, kuwunika njira zochiritsira, komanso mafunso aliwonse okhudza kufunafuna chithandizo ku Beijing. Dipatimenti Yapadziko Lonse ya Chipatala cha Oncology ku Beijing ili okonzeka kuthana ndi mavuto nanu, mwaukadaulo komanso mwachifundo.
Nthawi yotumizira: Epulo-23-2026
